The World Health Organization will start large-scale testing of an experimental Ebola vaccine in Guinea on Saturday to see how effective it might be in preventing future outbreaks of the deadly virus.
Arrowhead Research Corporation, a biopharmaceutical company developing targeted RNAi...
Liberia released its last Ebola patient, a 58-year old teacher, from a treatment center on...
Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine TechnologyMarch 5, 2015 3:23 pm | News | Comments
The Bill & Melinda Gates Foundation and CureVac today announced that the foundation has made...
A provocative study in mice suggests something as simple as breathing in extra oxygen might give immune cells a boost in attacking cancer.
The Supreme Court argument over subsidies that help millions of people afford their health insurance suggests that the Obama administration has two chances to attract one critical vote.
In an encouraging development for consumers worried about antibiotics in their milk, a new Food and Drug Administration study showed little evidence of drug contamination after surveying almost 2,000 dairy farms.
Mallinckrodt and Ikaria have entered into a definitive agreement under which a subsidiary of Mallinckrodt will acquire Ikaria, Inc. from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion.
Biosimilar approvals in the United States are expected to increase during the next five years, but safety concerns among physicians and the need for greater regulatory clarity concerning therapeutic interchangeability could hinder market uptake, according to a study recently completed by the Tufts Center for the Study of Drug Development.
The miserable flu season is winding down but not quite over yet, health officials said Wednesday, even as the government picked what it hoped would be a better vaccine recipe for next fall and winter.
Four patients at Cedars-Sinai Medical Center have been infected with an antibiotic-resistant "superbug" linked to a type of medical scope that's used on more than a half-million people in the U.S. every year, the hospital said Wednesday.
AbbVie and Pharmacyclics have announced a definitive agreement under which AbbVie will acquire Pharmacyclics, and its flagship asset Imbruvica (ibrutinib), a highly effective treatment for hematologic malignancies.
Baxter International and SuppreMol GmbH have announced that Baxter has acquired SuppreMol for EUR 200 million (approximately $225M USD) before working capital and other adjustments.
Patheon has reached a definitive agreement to acquire IRIX Pharmaceuticals, a company headquartered in Florence, S.C., that specializes in difficult to manufacture Active Pharmaceutical Ingredient (API) needs for drugs from early and late development, through commercial launch.
UPM Pharmaceuticals, a division of Gregory Pharmaceutical Holdings, Inc., has reached an agreement with Sprout Pharmaceuticals to manufacture Flibanserin 100 mg tablets.
Georgia officials waffled on whether to proceed with an execution when the lethal injection drug was discovered to have a cloudy appearance, according to a court filing, and one expert said their decision to postpone it was the right move.
FDA Approves Opdivo for the Treatment of Patients with Previously Treated Metastatic Squamous Non-Small Cell Lung CancerMarch 4, 2015 11:04 pm | News | Comments
Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) injection, for intravenous use, for the treatment of patients with metastatic squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.
Eisai and Merck have announced a clinical trial collaboration to evaluate the safety, tolerability and efficacy of Merck’s anti-PD-1 therapy, pembrolizumab, in combination with Eisai oncology compounds lenvatinib mesylate and eribulin mesylate.
The American Chemistry Council announced an ad campaign highlighting recent evaluations of bisphenol A as "safe." The ads--running in USA Today, the Wall Street Journal and on consumer, news and health websites--urge readers to "listen to the science" on BPA, a synthetic compound found in many plastics and resins.